Clinical Trial Update: Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluating ketamine with cognitive training for suicidality in a medical setting was terminated, with results posted in January 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Suicidality
• Suicide Attempt

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Rebecca Price | Conditions: Suicide, Attempted | Phase 4 | Status: TERMINATED | Results posted: 2023-01-10